Pharmacists are expected to play a central role in optimising medicines affected by pharmacogenomics (PGx), which refers to the variable effects that a patient’s genome can have on their response to a medicine[1]. From service development and identifying when PGx is indicated, to patient counselling and the interpretation of PGx results, pharmacists are ideally placed […]
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: